Literature DB >> 2956236

Immunity in dilated cardiomyopathy.

S K Das, J T Cassidy, S A Huber.   

Abstract

Although several immunologic parameters have been found to be abnormal, their precise relationship to the cause of the disease remains unclear. It is believed that a virus initiating a bout of myocarditis may play a role in the perpetuation of the chronic phase, probably via immunologic mediation. A selection acquired defect or damage to a subpopulation of suppressor T lymphocytes is possible, providing the basis for the development of an autoimmune disorder. Studies in mice have shown a clear link between active viral myocarditis and the subsequent development of cardiomyopathy. However, the trigger mechanism that initiates the cardiomyopathy is still elusive. Specific antigens, possibly altered virus or damaged cardiac tissue, may be playing the role of the "hidden or cloistered" antigen in eliciting the immunologic reactions through a cytotoxic T-cell mechanism. Identification and isolation of the specific "antigen" in question could resolve the dilemmas about the immunopathogenesis of cardiomyopathy in humans.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2956236     DOI: 10.1007/bf02072394

Source DB:  PubMed          Journal:  Heart Vessels Suppl        ISSN: 0935-736X


  28 in total

1.  Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy.

Authors:  R E Fowles; C P Bieber; E B Stinson
Journal:  Circulation       Date:  1979-03       Impact factor: 29.690

2.  Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease.

Authors:  J F Woodruff; J J Woodruff
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

Review 3.  The significance of heart-reactive antibodies in heart disease.

Authors:  S K Das; J T Cassidy; R E Petty
Journal:  Chest       Date:  1974-08       Impact factor: 9.410

4.  Residual pathologic changes following murine coxsackie A and B myocarditis.

Authors:  F M Wilson; Q R Miranda; J L Chason; A M Lerner
Journal:  Am J Pathol       Date:  1969-05       Impact factor: 4.307

5.  Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy.

Authors:  J L Anderson; J F Carlquist; E H Hammond
Journal:  Lancet       Date:  1982-11-20       Impact factor: 79.321

6.  [Cardiac diseases and anti-heart cellular autoimmunity].

Authors:  R Moulias; G Lafitte; M Komajda; C Buffet; F Congy; A Wang
Journal:  Coeur Med Interne       Date:  1978 Apr-Jun

7.  Cell-mediated cytotoxicity to cardiac cells of lymphocytes from patients with primary myocardial disease.

Authors:  B Jacobs; Y Matsuda; S Deodhar; E Shirey
Journal:  Am J Clin Pathol       Date:  1979-07       Impact factor: 2.493

8.  Cardiac function in patients with prior myocarditis.

Authors:  S K Das; T J Brady; J H Thrall; B Pitt
Journal:  J Nucl Med       Date:  1980-07       Impact factor: 10.057

9.  An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus.

Authors:  A Matsumori; C Kawai
Journal:  Circulation       Date:  1982-08       Impact factor: 29.690

10.  Assessment of antibody mediated cytolysis of adult cardiocytes isolated by centrifugation in a continuous gradient of Percoll in patients with acute myocarditis.

Authors:  B Maisch; R Trostel-Soeder; P A Berg; K Kochsiek
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.